Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Background: Shufeng Jiedu (SFJD) capsules can be used as adjunctive treatment for patients with community-acquired pneumonia, but the effectiveness and safety of SFJD are not clear. This review aims to evaluate the effectiveness and safety of SFJD based on randomized controlled trials (RCTs).Methods...

Full description

Bibliographic Details
Main Authors: Xiao-Wen Zhang, Ru-Yu Xia, Jia-Qi Gao, Jin-Jun Liu, De-Hao Xu, Xun Li, Xiao-Yang Hu, Merlin Willcox, Michael Moore, Meng-Yuan Dai, Jeanne Trill, Yu-Tong Fei, Jian-Ping Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Pharmacology
Subjects:
Chinese patent medicine
shufeng jiedu capsules
community-acquired pneumonia
systematic review
meta-analysis
randomized controlled trial
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.923395/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.923395/full

Similar Items